KCM
BHC icon

KRS Capital Management’s Bausch Health BHC Stock Holding History

KRS Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,500
Closed -$69K – 144
2021
Q4 		$69K Buy
+2,500
New +$66.9K 0.06% 207

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

KRS Capital Management's BHC Position: Q1 2022 in Review

KRS Capital Management sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 2,500 shares — an estimated $69K sold.

KRS Capital Management first reported a position in BHC in Q4 2021 and held it in 1 quarter. The position peaked at $69K in Q4 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • KRS Capital Management reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • KRS Capital Management sold 2,500 Bausch Health shares in Q1 2022, an estimated $69K.
  • KRS Capital Management first reported a position in Bausch Health in Q4 2021 and held it in 1 quarter.
  • KRS Capital Management's Bausch Health position peaked at $69K in Q4 2021.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.